1. Home
  2. KOD vs CCRD Comparison

KOD vs CCRD Comparison

Compare KOD & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • CCRD
  • Stock Information
  • Founded
  • KOD 2009
  • CCRD 1973
  • Country
  • KOD United States
  • CCRD United States
  • Employees
  • KOD N/A
  • CCRD N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • CCRD
  • Sector
  • KOD Health Care
  • CCRD
  • Exchange
  • KOD Nasdaq
  • CCRD Nasdaq
  • Market Cap
  • KOD 188.9M
  • CCRD 157.9M
  • IPO Year
  • KOD 2018
  • CCRD N/A
  • Fundamental
  • Price
  • KOD $3.95
  • CCRD $28.88
  • Analyst Decision
  • KOD Hold
  • CCRD Hold
  • Analyst Count
  • KOD 3
  • CCRD 1
  • Target Price
  • KOD $9.00
  • CCRD $21.00
  • AVG Volume (30 Days)
  • KOD 293.9K
  • CCRD 113.2K
  • Earning Date
  • KOD 08-13-2025
  • CCRD 07-31-2025
  • Dividend Yield
  • KOD N/A
  • CCRD N/A
  • EPS Growth
  • KOD N/A
  • CCRD 187.14
  • EPS
  • KOD N/A
  • CCRD 0.86
  • Revenue
  • KOD N/A
  • CCRD $61,011,000.00
  • Revenue This Year
  • KOD N/A
  • CCRD $17.35
  • Revenue Next Year
  • KOD N/A
  • CCRD N/A
  • P/E Ratio
  • KOD N/A
  • CCRD $33.51
  • Revenue Growth
  • KOD N/A
  • CCRD 12.31
  • 52 Week Low
  • KOD $1.92
  • CCRD $11.57
  • 52 Week High
  • KOD $11.60
  • CCRD $31.99
  • Technical
  • Relative Strength Index (RSI)
  • KOD 53.45
  • CCRD 59.82
  • Support Level
  • KOD $3.60
  • CCRD $27.76
  • Resistance Level
  • KOD $3.97
  • CCRD $29.88
  • Average True Range (ATR)
  • KOD 0.24
  • CCRD 1.13
  • MACD
  • KOD 0.01
  • CCRD -0.24
  • Stochastic Oscillator
  • KOD 63.43
  • CCRD 59.93

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About CCRD CoreCard Corporation

CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.

Share on Social Networks: